Cargando…
Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
There is an established, link between psychosis and metabolic abnormalities, such as altered glucose metabolism and dyslipidemia, which often precede the initiation of antipsychotic treatment. It is known that obesity-associated metabolic disorders are promoted by activation of specific cannabinoid...
Autores principales: | Dickens, Alex M., Borgan, Faith, Laurikainen, Heikki, Lamichhane, Santosh, Marques, Tiago, Rönkkö, Tuukka, Veronese, Mattia, Lindeman, Tuomas, Hyötyläinen, Tuulia, Howes, Oliver, Hietala, Jarmo, Orešič, Matej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450081/ https://www.ncbi.nlm.nih.gov/pubmed/32848142 http://dx.doi.org/10.1038/s41537-020-00110-7 |
Ejemplares similares
-
The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study
por: Borgan, Faith, et al.
Publicado: (2019) -
Metabolic alterations in immune cells associate with progression to type 1 diabetes
por: Sen, Partho, et al.
Publicado: (2020) -
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019) -
42.4 THE ENDOCANNABINOID SYSTEM IN FIRST-EPISODE PSYCHOSIS
por: Hietala, Jarmo
Publicado: (2018) -
Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry
por: Salihović, Samira, et al.
Publicado: (2019)